The BRAIN Conference | Two-day online conference
BRAIN has published landmark papers in clinical neurology and translational neuroscience since 1878. The Guarantors of BRAIN are devoted to promoting teaching, education & research in neurology and related disciplines.
BRAIN and its Guarantors are excited to announce a new venture: The BRAIN Conference! This two-day conference will feature a selection of fantastic speakers, invited by our conference Chairs from around the globe.
They will deliver clinical teaching talks and research presentations across the range of neurology, neuropsychiatry and neuroscience.
This conference will take place on March 4-5th 2021 and be fully online.
The following areas will be covered:
Cognitive Neurology (Chair: Masud Husain)
Epilepsy (Chair: Dimitri Kullman)
Neurodegenerative (Chair: Anne Rosser),
Neurogenetics (Chair: Nicholas Wood),
Headache (Chair: Peter Goadsby),
Traumatic Brain Injury (Chair: Dave Sharp),
Nerve (Chair: Mary Reilly),
Stroke (Chair: Hugh Markus),
Neuroinflammation/MS (Chair: Olga Ciccarelli),
Movement Disorders (Chair: Anette Schrag),
Infectious Disease (Chair: Tom Solomon),
Neuropsychiatry (Chair: Paul Fletcher),
COVID Neurology (Chair: Mike Zandi) and
Muscle (Chair: Mike Hanna)
There will also have short ‘data blitz’ presentations in these sessions – BRAIN encourages all early-career researchers to submit an abstract to be considered.
Abstract submission now open!
BRAIN is keen to make this conference accessible to all – registration is only GBP 10 [free if you cannot afford this].
Register Now
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.